TSX:WELLHealthcare
Assessing WELL Health Technologies (TSX:WELL) Valuation After 2025 Results And New 2026 Guidance
What the latest results mean for WELL Health Technologies
WELL Health Technologies (TSX:WELL) has drawn attention after releasing full year 2025 earnings, reporting CA$1.40b in sales alongside a net loss of CA$7.36m, and issuing 2026 revenue guidance of CA$1.55b to CA$1.65b.
See our latest analysis for WELL Health Technologies.
The full year 2025 results and 2026 revenue guidance arrive after a 1 year total shareholder return decline of 12.19% and a 5 year total shareholder return decline...